512 related articles for article (PubMed ID: 22789011)
1. Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells.
Ruan JW; Liao YC; Lua I; Li MH; Hsu CY; Chen JH
Breast Cancer Res; 2012 Jul; 14(4):R106. PubMed ID: 22789011
[TBL] [Abstract][Full Text] [Related]
2. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
[TBL] [Abstract][Full Text] [Related]
3. Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling.
Liao YC; Ruan JW; Lua I; Li MH; Chen WL; Wang JR; Kao RH; Chen JH
Oncogene; 2012 Jun; 31(25):3086-97. PubMed ID: 22002306
[TBL] [Abstract][Full Text] [Related]
4. Chemokine signaling via the CXCR2 receptor reinforces senescence.
Acosta JC; O'Loghlen A; Banito A; Guijarro MV; Augert A; Raguz S; Fumagalli M; Da Costa M; Brown C; Popov N; Takatsu Y; Melamed J; d'Adda di Fagagna F; Bernard D; Hernando E; Gil J
Cell; 2008 Jun; 133(6):1006-18. PubMed ID: 18555777
[TBL] [Abstract][Full Text] [Related]
5. The inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cells.
Leibovich-Rivkin T; Liubomirski Y; Meshel T; Abashidze A; Brisker D; Solomon H; Rotter V; Weil M; Ben-Baruch A
BMC Cancer; 2014 Mar; 14():158. PubMed ID: 24598028
[TBL] [Abstract][Full Text] [Related]
6. Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.
Bi X; Hameed M; Mirani N; Pimenta EM; Anari J; Barnes BJ
Breast Cancer Res; 2011; 13(6):R111. PubMed ID: 22053985
[TBL] [Abstract][Full Text] [Related]
7. Macrophages promote fibroblast growth factor receptor-driven tumor cell migration and invasion in a CXCR2-dependent manner.
Bohrer LR; Schwertfeger KL
Mol Cancer Res; 2012 Oct; 10(10):1294-305. PubMed ID: 22893608
[TBL] [Abstract][Full Text] [Related]
8. Cooperation between p21 and Akt is required for p53-dependent cellular senescence.
Kim YY; Jee HJ; Um JH; Kim YM; Bae SS; Yun J
Aging Cell; 2017 Oct; 16(5):1094-1103. PubMed ID: 28691365
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor alpha inhibits senescence-like phenotype and facilitates transformation induced by oncogenic ras in human mammary epithelial cells.
Liu Z; Wang L; Yang J; Bandyopadhyay A; Kaklamani V; Wang S; Sun LZ
Oncotarget; 2016 Jun; 7(26):39097-39107. PubMed ID: 27259243
[TBL] [Abstract][Full Text] [Related]
10. A mitochondrial ROS pathway controls matrix metalloproteinase 9 levels and invasive properties in RAS-activated cancer cells.
Mori K; Uchida T; Yoshie T; Mizote Y; Ishikawa F; Katsuyama M; Shibanuma M
FEBS J; 2019 Feb; 286(3):459-478. PubMed ID: 30281903
[TBL] [Abstract][Full Text] [Related]
11. CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways.
Sobolik T; Su YJ; Wells S; Ayers GD; Cook RS; Richmond A
Mol Biol Cell; 2014 Mar; 25(5):566-82. PubMed ID: 24403602
[TBL] [Abstract][Full Text] [Related]
12. CXCR2: A Novel Mediator of Mammary Tumor Bone Metastasis.
Sharma B; Nannuru KC; Saxena S; Varney ML; Singh RK
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871004
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence.
Volonte D; Vyas AR; Chen C; Dacic S; Stabile LP; Kurland BF; Abberbock SR; Burns TF; Herman JG; Di YP; Galbiati F
J Biol Chem; 2018 Feb; 293(5):1794-1809. PubMed ID: 29247004
[TBL] [Abstract][Full Text] [Related]
14. Chemokine receptor CXCR2 is transactivated by p53 and induces p38-mediated cellular senescence in response to DNA damage.
Guo H; Liu Z; Xu B; Hu H; Wei Z; Liu Q; Zhang X; Ding X; Wang Y; Zhao M; Gong Y; Shao C
Aging Cell; 2013 Dec; 12(6):1110-21. PubMed ID: 23869868
[TBL] [Abstract][Full Text] [Related]
15. E2F1 induces pituitary tumor transforming gene (PTTG1) expression in human pituitary tumors.
Zhou C; Wawrowsky K; Bannykh S; Gutman S; Melmed S
Mol Endocrinol; 2009 Dec; 23(12):2000-12. PubMed ID: 19837943
[TBL] [Abstract][Full Text] [Related]
16. Association of CXCR1 and 2 expressions with gastric cancer metastasis in ex vivo and tumor cell invasion in vitro.
Li Z; Wang Y; Dong S; Ge C; Xiao Y; Li R; Ma X; Xue Y; Zhang Q; Lv J; Tan Q; Zhu Z; Song X; Tan J
Cytokine; 2014 Sep; 69(1):6-13. PubMed ID: 25022956
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved.
Vizioli MG; Santos J; Pilotti S; Mazzoni M; Anania MC; Miranda C; Pagliardini S; Pierotti MA; Gil J; Greco A
Oncotarget; 2014 Sep; 5(18):8270-83. PubMed ID: 25268744
[TBL] [Abstract][Full Text] [Related]
18. GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade.
Yung MM; Tang HW; Cai PC; Leung TH; Ngu SF; Chan KK; Xu D; Yang H; Ngan HY; Chan DW
Theranostics; 2018; 8(5):1270-1285. PubMed ID: 29507619
[TBL] [Abstract][Full Text] [Related]
19. Induction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells.
Sharma B; Varney ML; Saxena S; Wu L; Singh RK
Cancer Lett; 2016 Mar; 372(2):192-200. PubMed ID: 26797460
[TBL] [Abstract][Full Text] [Related]
20. Proteomics evaluation of MDA-MB-231 breast cancer cells in response to RNAi-induced silencing of hPTTG.
Khazaei G; Shamsabadi FT; Yamchi A; Golalipour M; Jhingan GD; Shahbazi M
Life Sci; 2019 Dec; 239():116873. PubMed ID: 31521689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]